No single cough medicine has been proven to cure a COVID cough, but several over-the-counter and prescription options can make the coughing more bearable while your body fights the infection. Dextromethorphan, the suppressant in most drugstore cough syrups, showed meaningful reductions in cough severity and frequency in a clinical trial specifically focused on COVID patients. Beyond that familiar standby, the picture gets more interesting: inhaled corticosteroids, honey, prescription suppressants, and even antivirals all play roles depending on how severe your cough is and how long it has lasted.
Why COVID Makes You Cough So Much
SARS-CoV-2 does not just inflame your airways the way a common cold does. Researchers believe the virus triggers a state of heightened cough sensitivity by directly affecting the vagus nerve, the long nerve that runs from your brainstem down through your throat and chest. The virus appears to cause inflammation in and around those nerve fibers, essentially turning up the dial on your cough reflex so that stimuli that would normally be ignored suddenly provoke a coughing fit.1PubMed Central. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses This nerve-driven hypersensitivity helps explain why COVID coughs can linger for weeks or months after the acute infection clears, and it also explains why different medications work at different stages of the illness.
Dextromethorphan and Other Over-the-Counter Suppressants
Dextromethorphan (often abbreviated DXM on labels) is the active ingredient in brands like Robitussin DM and Delsym. In a randomized controlled trial comparing DXM against gabapentin and a gabapentin-montelukast combination for COVID-related cough, DXM produced a significantly greater reduction in both cough severity and standardized cough scores from baseline.2PubMed Central. The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A randomized, controlled clinical trial That makes it a reasonable first-line choice if your cough is dry and persistent. DXM works by suppressing the cough reflex in the brain rather than treating the underlying inflammation, so it is purely a comfort measure.
Guaifenesin, the expectorant found in Mucinex and many combination products, serves a different purpose. It thins mucus rather than suppressing the urge to cough. A hypothesis paper proposed that mucolytics and expectorants like guaifenesin could help COVID patients by reducing the thick mucus buildup in the lungs and potentially interfering with a protein the virus uses to enter cells.3PubMed Central. Protective potential of expectorants against COVID-19 That antiviral angle remains speculative, but the basic mucus-thinning benefit is real: if your cough is wet and productive, guaifenesin can make it easier to clear your airways. If your cough is dry and hacking, guaifenesin alone probably will not help much, and DXM is a better fit.
Many combination products contain both DXM and guaifenesin. If you are unsure whether your cough is “wet” or “dry,” a combination product hedges your bets, though it is always worth reading the label for added ingredients like acetaminophen or pseudoephedrine that you may not need.
Prescription Cough Suppressants
When over-the-counter options are not enough, doctors have a few prescription tools. Benzonatate (brand name Tessalon Perles) was one of the most commonly used medications for COVID cough in outpatient and telemedicine settings during the pandemic. In a survey of healthcare providers, roughly seven in ten rated benzonatate as moderately or very effective for COVID-related cough, and providers who followed patients over time were even more likely to use it.4PubMed Central. A Survey of Provider-Reported Use and Perceived Effectiveness of Medications for Symptom Management in Telemedicine and Outpatient Visits for Mild COVID-19 Benzonatate works by numbing the stretch receptors in the lungs and airways, dampening the signal that tells your brain to cough.
For truly distressing coughs that resist other treatments, opioid-based suppressants remain an option. UK guidelines during the pandemic noted that short-term use of codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution could be considered to suppress coughing in adults when the cough was severe enough to warrant it.5BMJ. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases These carry well-known downsides, including drowsiness, constipation, and dependence risk, so they are reserved for short courses in patients whose quality of life is seriously affected.
Inhaled Corticosteroids
One of the more encouraging treatment findings to emerge during the pandemic involved inhaled budesonide, a steroid typically used for asthma. The STOIC trial found that people who started inhaled budesonide early in their COVID illness recovered about a day faster and were far less likely to need emergency care or hospitalization: only about 1% of the budesonide group deteriorated compared with 14% in the usual-care group.6The Lancet Respiratory Medicine. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial A larger UK trial (PRINCIPLE) confirmed the benefit, finding that budesonide shortened recovery time by roughly three days compared with usual care.7The Lancet. Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
A Cochrane systematic review pooling data from multiple trials concluded that inhaled corticosteroids probably reduce the combined risk of hospitalization or death by about 28% and increase the likelihood that all initial symptoms resolve within two weeks.8Cochrane Database of Systematic Reviews. Inhaled corticosteroids for the treatment of COVID-19 While these trials measured overall recovery rather than cough alone, cough was a prominent symptom in most participants, and the anti-inflammatory action directly addresses the airway irritation driving the cough. Inhaled budesonide is available by prescription and is generally well tolerated, with few of the side effects associated with oral steroids.
Antivirals and Their Indirect Effect on Cough
Antiviral treatments like Paxlovid (nirmatrelvir/ritonavir) are not cough medicines in any conventional sense. They work by blocking the virus from replicating. But stopping viral replication early means less inflammation, which translates to faster symptom relief across the board, including cough. One clinical trial found that Paxlovid quickly alleviated symptoms such as fever, sore throat, and cough during the acute phase, which may also be part of why it appeared to reduce the incidence of lingering post-COVID symptoms.9PubMed Central. Impact of Paxlovid on in-hospital outcomes and post-COVID-19 condition in adult patients infected with SARS-CoV-2 Omicron variant: A non-randomized controlled clinical trial
If you are eligible for Paxlovid (generally people at higher risk for severe disease, started within the first five days of symptoms), getting it may be the single most impactful thing you can do for your cough, because it attacks the root cause rather than just masking the symptom. That said, Paxlovid interacts with a wide range of medications. A review of the 50 most commonly prescribed drugs found that about 30% had a potential interaction with Paxlovid.10PubMed. Evaluating Drug Interaction Risks: Nirmatrelvir & Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical Settings Your doctor or pharmacist will need to check your full medication list before prescribing it.
Honey as a Cough Remedy
Honey has been used for coughs for centuries, and the evidence behind it is surprisingly solid. A systematic review and meta-analysis covering multiple trials of upper respiratory infections found that honey reduced cough frequency and cough severity compared with usual care.11PubMed. Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis Those trials were not COVID-specific, but the mechanism is similar: honey coats and soothes irritated throat tissue and may have mild anti-inflammatory properties.
A trial that was COVID-specific tested a honey-based herbal syrup (containing honey and hyssop) in hospitalized patients with mild to moderate disease and found it significantly reduced cough severity compared with placebo.12Acta Medica Iranica. Evaluation of the Effect of “Honey Zufa” Herbal Syrup on Cough in Hospitalized Patients With COVID-19: A Double Blind Randomized Clinical Trial A spoonful of plain honey in warm water or tea is cheap, has virtually no side effects in adults, and can be used alongside other medications. The one firm restriction: never give honey to children under one year old, due to the risk of infant botulism.
Steam Inhalation and Gargling
Breathing in warm steam from a bowl of hot water or a steamy shower is a time-honored approach to congestion and cough. A review of available data acknowledged that steam inhalation provides symptomatic relief for COVID patients but cautioned that there is not enough evidence to support a role in treatment or prevention beyond comfort.13PubMed Central. Data on steam inhalation in combating CoVid-19 In other words, it can make you feel better in the moment, but do not expect it to shorten your illness.
Gargling with saline (salt water) showed more promise in one randomized trial, where participants who gargled saline achieved clinical recovery about four days sooner.14PubMed Central. Impact of Steam Inhalation, Saline Gargling, and Povidone-Iodine Gargling on Clinical Outcome of COVID-19 Patients in Bengaluru, Karnataka: A Randomized Control Trial That is a single study, so the finding needs replication, but saline gargling is free and harmless enough that there is little reason not to try it if you have a sore, tickly throat feeding into your cough.
When the Cough Will Not Go Away
Most COVID coughs resolve within two to four weeks, but for some people the cough stretches on for months, becoming part of what is commonly called long COVID. The underlying driver of persistent post-COVID cough appears to be continued nerve-level inflammation and heightened cough-reflex sensitivity, even after the virus itself has been cleared.15PubMed Central. Approach to post COVID-19 persistent cough: A narrative review Standard cough suppressants like DXM tend to become less effective at this stage because the problem has shifted from active infection to a misfiring nervous system.
For persistent cough that does not respond to early symptomatic treatment, inhaled corticosteroids can be tried to tamp down lingering airway inflammation. If that does not work, neuromodulators like gabapentin and pregabalin, drugs more commonly associated with nerve pain and seizures, have shown benefit for chronic refractory cough. These medications quiet the overexcited nerve pathways driving the cough hypersensitivity.16The Lancet Respiratory Medicine. COVID-19 associated cough and hyper-responsiveness – Section: Management of COVID-19-associated cough They can also help with other long COVID symptoms like pain, though they carry their own side effects, including drowsiness and potential worsening of brain fog. Speech and language therapy focused on cough-suppression techniques is another approach gaining traction in chronic cough management, offering a drug-free option for people who prefer to avoid additional medications.17Annual Reviews. Chronic Cough Hypersensitivity as a Neuropathic Disorder: Implications for Management and New Treatments
Children and Cough Medicine Safety
Most over-the-counter cough suppressants are not recommended for children under four, and many labels extend the warning to children under six or even twelve. The active ingredients have not been shown to work well in young children, and dosing errors carry real risks. During the pandemic, data on pediatric exposures to nonprescription cough, cold, and pain medications showed a brief dip at the start of lockdowns, likely because children were getting sick less often. But within about a year and a half, exposure rates climbed back to pre-pandemic levels, and they continued rising month over month.18Springer Link / Clinical Drug Investigation. Trends in US Pediatric Unintentional Nonprescription Cold and Cough, Analgesic and Antipyretic Drug Exposure Cases amid the COVID-19 Pandemic The take-home point is straightforward: for young children with a COVID cough, honey (if over one year old), fluids, humidified air, and a call to the pediatrician are safer first steps than reaching for an adult cough syrup and estimating a dose.
Herbal and Botanical Extracts
Pelargonium sidoides extract (sold under brand names like Umcka or Umckaloabo) is a plant-derived remedy with a longer track record in acute respiratory infections than most herbal products. A meta-analysis of randomized, placebo-controlled trials found that roughly 80% of children and adolescents treated with the extract saw at least a 50% reduction in cough intensity, compared with about 41% of those on placebo.19PubMed Central. Effects of Pelargonium sidoides extract EPs 7630 on acute cough and quality of life – a meta-analysis of randomized, placebo-controlled trials Those trials covered general acute respiratory infections rather than COVID specifically, but the cough-relieving effect is notable. If you are looking for a supplement with at least some clinical evidence behind it, pelargonium extract is one of the few that clears the bar.
The Placebo Factor in Cough Treatment
Something worth keeping in mind whenever you evaluate cough remedies: the placebo effect for cough is unusually powerful. Because cough has a voluntary component and is influenced by expectation, people who believe they are taking an active medicine can unconsciously suppress their cough, which muddles the results of clinical trials.20PubMed Central. The Powerful Placebo Effect in Cough: Relevance to Treatment and Clinical Trials This is not a reason to dismiss treatments that work, but it does mean you should be cautious about anecdotes. If a friend swears a particular herbal tea cured their COVID cough in a day, the improvement may have been partly expectation, partly the natural course of the illness, and partly the soothing warmth of the drink. That does not make the relief any less real to the person experiencing it, but it is why controlled trials matter more for cough remedies than almost any other symptom category.
Putting Together a Practical Plan
The right approach depends on where you are in the illness. During the first few days, the priority is treating the infection itself. If you qualify for antivirals, get them started; faster viral clearance means a shorter, less intense cough. For symptom relief alongside antivirals or on their own, DXM-containing cough suppressants are a solid over-the-counter option for dry cough, while guaifenesin helps if mucus is the main issue. Adding honey to warm drinks provides a genuine, evidence-backed boost. If over-the-counter products are not cutting it, ask your doctor about benzonatate or inhaled budesonide, both of which saw wide use during the pandemic with reasonable evidence of benefit.
If your cough is still hanging around after four weeks, the strategy shifts. At that point, the virus is likely gone and the problem is residual airway inflammation or nerve sensitization. Inhaled corticosteroids are a logical next step, and if those do not help, a referral to a specialist who can consider neuromodulators or cough-specific speech therapy is worth pursuing. Persistent cough after COVID is common enough that most pulmonologists have a well-worn playbook for it at this point.